Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Ikena Oncology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
08/07/2023 8-K Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger, by and among Ikena Oncology, Inc., Portsmouth Merger Sub I, Inc., Portsmouth Merger Sub II, LLC, Pionyr Immunotherapeutics, Inc. and Fortis Advisors LLC, as securityholder agent",
"Certificate of Designations of Series A Non-Voting Convertible Preferred Stock",
"Contingent Value Rights Agreement, by and between Ikena Oncology, Inc. and Computershare Trust Company N.A, as rights agent",
"Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction"
06/30/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/15/2023 8-K Investor presentation
Docs: "Underwriting Agreement, by and between Ikena Oncology, Inc. and Cowen and Company, LLC, as representative of the several underwriters named therein",
"Opinion of Goodwin Procter LLP",
"Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline",
"Ikena Oncology Inc. Corporate Presentation",
"Ikena Oncology Announces $40 Million Underwritten Offering"
04/17/2023 8-K Quarterly results
12/19/2022 8-K Quarterly results
11/28/2022 8-K Investor presentation
Docs: "Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update",
"Ikena Oncology, Inc. Corporate Presentation"
06/10/2022 8-K Quarterly results
04/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer and Head of Corporate Development"
04/06/2022 8-K Other Events  Interactive Data
Docs: "FORM 8-K"
02/24/2022 8-K Quarterly results
01/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/26/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K",
"Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors"
11/10/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Ikena Oncology, Inc. Corporate Presentation",
"Ikena Oncology, Inc. Corporate Presentation"
08/12/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
04/15/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy